干旱区生态环境知识资源中心(Arid): Immune-desert tumor microenvironment in SMARCA4-deficient thoracic sarcomas with limited efficacy of immune checkpoint inhibitors.

Arid

DOI	10.1200/JCO.2021.39.15_suppl.11552
	Immune-desert tumor microenvironment in SMARCA4-deficient thoracic sarcomas with limited efficacy of immune checkpoint inhibitors.
	Gantzer, Justine; Davidson, Guillaume; Vokshi, Bujamin; Weingertner, Noelle; Bougouin, Antoine; Moreira, Marco; Lindner, Veronique; Lacroix, Guillaume; Mascaux, Celine; Chenard, Marie Pierre; Davidson, Irwin; Kurtz, Jean Emmanuel; Sautes-Fridman, Catherine; Fridman, Wolf-Herman; Malouf, Gabriel
来源期刊	JOURNAL OF CLINICAL ONCOLOGY
ISSN	0732-183X
EISSN	1527-7755
出版年	2021
卷号	39 期号:15
类型	Meeting Abstract
语种	英语
收录类别	SCI-E
WOS记录号	WOS:000708120606088
WOS类目	Oncology
WOS研究方向	Oncology
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/368766
作者单位	ICANS, Med Oncol Dept, Strasbourg, France; IGBMC, Illkirch Graffenstaden, France; CHRU Strasbourg, Dept Pathol, Strasbourg, France; Ctr Rech Cordeliers, Paris, France; Hop Univ Strasbourg, Strasbourg, France; Hop Univ Strasbourg, Dept Pneumol, Strasbourg, France; IGBMC, Strasbourg, France; Gineco, Strasbourg, France; Inst Cancerol Strasbourg Europe, Strasbourg, France; INSERM, Cordeliers Res Ctr, UMR S 1138, Paris, France; Inst Cancerol Strasbourg ICANS, Dept Med Oncol, Strasbourg, France
推荐引用方式 GB/T 7714	Gantzer, Justine,Davidson, Guillaume,Vokshi, Bujamin,et al. Immune-desert tumor microenvironment in SMARCA4-deficient thoracic sarcomas with limited efficacy of immune checkpoint inhibitors.[J],2021,39(15).
APA	Gantzer, Justine.,Davidson, Guillaume.,Vokshi, Bujamin.,Weingertner, Noelle.,Bougouin, Antoine.,...&Malouf, Gabriel.(2021).Immune-desert tumor microenvironment in SMARCA4-deficient thoracic sarcomas with limited efficacy of immune checkpoint inhibitors..JOURNAL OF CLINICAL ONCOLOGY,39(15).
MLA	Gantzer, Justine,et al."Immune-desert tumor microenvironment in SMARCA4-deficient thoracic sarcomas with limited efficacy of immune checkpoint inhibitors.".JOURNAL OF CLINICAL ONCOLOGY 39.15(2021).